BIVI
Income statement / Annual
Last year (2024), BioVie Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, BioVie Inc.'s net income was -$32.12 M.
See BioVie Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$229,377.00 |
$266,842.00 |
$237,421.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$51,036.00 |
$0.00 |
Gross Profit |
-$229,377.00 |
-$266,842.00 |
-$237,421.00 |
-$229,377.00 |
-$229,377.00 |
-$229,377.00 |
-$229,377.00 |
-$229,377.00 |
-$51,036.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$23.10 M
|
$33.30 M
|
$17.26 M
|
$133.19 M
|
$1.15 M
|
$1.01 M
|
$370,853.00
|
$466,354.00
|
$37,901.00
|
$4,196.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.26 M
|
$1.77 M
|
$857,883.00
|
$343,091.00
|
$229,181.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$8.85 M
|
$11.55 M
|
$9.77 M
|
$4.64 M
|
$1.31 M
|
$1.26 M
|
$1.77 M
|
$857,883.00
|
$343,091.00
|
$229,181.00
|
Other Expenses |
$0.00 |
$229.38 M |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$229,377.00 |
$51,036.00 |
$212,710.00 |
Operating Expenses |
$31.95 M |
$45.08 M |
$27.25 M |
$138.05 M |
$2.69 M |
$2.50 M |
$2.37 M |
$1.55 M |
$432,028.00 |
$233,377.00 |
Cost And Expenses |
$32.18 M |
$45.08 M |
$27.25 M |
$138.05 M |
$2.69 M |
$2.50 M |
$2.37 M |
$1.55 M |
$432,028.00 |
$233,377.00 |
Interest Income |
$0.00 |
$562,264.00 |
$44,080.00 |
$21,971.00 |
$234.00 |
$1,159.00 |
$4.00 |
$14.00 |
$186.00 |
$369.00 |
Interest Expense |
$1.76 M |
$4.30 M |
$2.16 M |
$559,455.00 |
$4.77 M |
$273.00 |
$40,960.00 |
$0.00 |
$81.00 |
$0.00 |
Depreciation &
Amortization |
$229,377.00
|
$266,842.00
|
$237,421.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$51,036.00
|
$369.00
|
EBITDA |
-$31.95 M
|
-$45.69 M
|
-$23.68 M
|
-$137.80 M
|
-$2.46 M
|
-$2.27 M
|
-$2.14 M
|
-$1.32 M
|
-$380,806.00
|
-$233,008.00
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$59,052.00
|
-$5.18 M
|
$1.17 M
|
$7.80 M
|
-$13.98 M
|
$52,286.00
|
-$40,956.00
|
$222,942.00
|
$105.00
|
$369.00
|
Income Before Tax |
-$32.12 M |
-$50.26 M |
-$26.08 M |
-$130.25 M |
-$16.68 M |
-$2.44 M |
-$2.41 M |
-$1.33 M |
-$431,923.00 |
-$233,008.00 |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00 |
$4.30 M |
-$3.29 M |
$559,455.00 |
$4.77 M |
-$51,400.00 |
-$1.00 |
-$222,928.00 |
-$105.00 |
-$369.00 |
Net Income |
-$32.12 M |
-$50.26 M |
-$26.08 M |
-$183.85 M |
-$33.78 M |
-$2.49 M |
-$2.43 M |
-$1.33 M |
-$431,923.00 |
-$233,008.00 |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
EPS |
-7.3 |
-15.47 |
-10.58 |
-148.23 |
-68.52 |
-9.82 |
-31.77 |
-18.61 |
-6.19 |
-3.34 |
EPS Diluted |
-7.3 |
-15.5 |
-10.6 |
-148.23 |
-68.52 |
-9.82 |
-31.77 |
-18.61 |
-6.19 |
-3.34 |
Weighted Average Shares
Out |
$4.52 M
|
$3.24 M
|
$2.46 M
|
$1.24 M
|
$492,000.00
|
$253,000.00
|
$76,000.00
|
$71,000.00
|
$69,000.00
|
$69,000.00
|
Weighted Average Shares
Out Diluted |
$4.52 M
|
$3.25 M
|
$2.47 M
|
$1.24 M
|
$492,950.00
|
$253,961.00
|
$76,606.00
|
$71,513.00
|
$69,759.00
|
$69,768.00
|
Link |
|
|
|
|
|
|
|
|
|
|